Article Information
History
- February 2, 2022.
Article Versions
- Version 1 (January 31, 2022 - 17:54).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Erola Pairo-Castineira1,2,
- Jaime Cornelissen1,
- Konrad Rawlik2,
- Oriol Canela-Xandri1,2,
- Stacie K. Loftus3,
- William J. Pavan3,
- Kevin M. Brown4,
- Albert Tenesa1,2 and
- Ian J. Jackson1,*
- 1MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, EH4 2XU, UK
- 2Roslin Institute, University of Edinburgh, Easter Bush, EH25 9RG, UK
- 3National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892-2152, USA
- 4Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
- ↵* Corresponding author; email: ian.jackson{at}ed.ac.uk
Posted February 02, 2022.
